The Economic Times
English EditionEnglish Editionहिन्दी
| 09 March, 2021, 08:59 AM IST | E-Paper
Search
+

    Dr Reddy's seeks emergency use authorization for Russia's Sputnik V vaccine

    The Hyderabad-headquartered company, which had entered into a partnership with the Russian Direct Investment Fund (RDIF) last September to conduct clinical trials of Sputnik V and rights for its distribution in India, said it would present the trial data to the Indian regulator.

    Iran approves Russia's Sputnik V vaccine

    Iran, which is fighting the Middle East's deadliest outbreak, has said it will only rely on vaccines made by Russia, India or China, while also working to produce a homemade jab.

    Over 60% of Russians don't want Sputnik V vaccine, see coronavirus as biological weapon: Poll

    The Levada Center said a poll it conducted last month showed that 62% of people did not want to get Russia's domestically produced vaccine, and that the highest level of reluctance was identified among 18 to 24-year-olds.

    Russia's Sputnik V vaccine to seek India approval by March

    A source close to the drug regulator said the application could come within days and when approved, bolster India's 18-day-old immunisation campaign which has covered more than 4 million people with two other shots.

    Study: Russia's Sputnik V vaccine appears safe, effective

    Researchers say based on their trial, which involved about 20,000 people in Russia last fall, the vaccine is about 91 per cent effective and that the shot also appeared to prevent people from becoming severely ill with COVID-19. The study was published online Tuesday in the journal, Lancet.

    Expert panel reviews EUA application for Sputnik V vaccine; seeks immunogenicity, safety data

    Dr Reddy's Laboratories on February 19 said it had approached drugs regulator DCGI for emergency use authorisation (EUA) for the Russian vaccine.

    India may approve Russia's Sputnik V vaccine within next few weeks: Report

    Small human trials of the Russian vaccine have been ongoing in India, conducted by India's Dr. Reddy's Laboratories Ltd and supported by the Russian Direct Investment Fund (RDIF).

    Sputnik vaccine to cost less than $10 in India, nod likely soon

    Russian Development Investment Fund (RDIF), which is backing the Sputnik V vaccine, on Thursday said it expects to register the vaccine in India soon and will price it at less than $10 per dose.

    Dr Reddy’s fails to get approval for Sputnik V

    “The committee has asked the company to come back with immunogenicity data,” a government official said, asking not to be identified. Dr Reddy’s had approached the regulator on February 19 to get emergency approval for Sputnik V.

    Trials of Russian COVID-19 vaccine Sputnik V begin in UAE as cases rise

    The human trial, announced in October before the recent rise in cases, is initially seeking up to 500 volunteers to be vaccinated at a hospital in the emirate of Abu Dhabi. Two doses of the vaccine will be given, 20 days apart, to volunteers, the statement said. Participants will have to be 18 years or older, have not previously been infected with COVID-19 or participated in other COVID-19 vaccine trials, it said.

    Sputnik V vaccine goes live on social media

    The social media campaign will focus on progress of Sputnik V clinical trials, production and mass vaccination in different countries, according to a press statement.

    Pakistan approves Russia's Sputnik-V COVID-19 vaccine for emergency use

    "Sputnik has received EUA (emergency use authorisation)," the minister, Faisal Sultan, told Reuters in a WhatsApp text message.

    Lancet peer-reviewed study endorses Russia's Sputnik V Covid-19 vaccine

    Sputnik V uses two adenoviruses, AD 5 and AD 26, that target the spike protein of the SARS Cov2 virus. Companies such as AstraZeneca, Johnson & Johnson and CanSino are using one of these 2 vectors for their vaccines.

    Putin says Sputnik V vaccine could be produced in India and China

    Putin also proposed that the creation of a vaccine research centre for BRICS countries - Brazil, Russia, India, China and South Africa - be sped up, TASS reported.

    Russia will jointly produce Sputnik V vaccine for COVID-19 with India: Russian envoy

    Sputnik V vaccine has shown 92 per cent efficacy in preventing COVID-19, according to the interim trial results announced by the country's health ministry.

    Sputnik V vaccine 92% effective on COVID-19: Russia institute

    "We are responsible for monitoring the effectiveness of the Sputnik V vaccine among citizens who have received it as part of the mass vaccination programme," Oksana Drapkina, director of a research institute under the health ministry, said in a statement.

    Russia files to register its Sputnik V coronavirus vaccine in Europe

    The Sputnik V and EMA teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews.

    Sputnik V vaccine: India to produce about 300 mn doses of Russian vaccine in 2021

    Russia to test first samples of Sputnik V vaccine made in India; 300 million doses to be produced in 2021Sputnik V vaccine: India to produce about 300 mn doses of Russian vaccine in 2021

    Russia submits application to WHO for accelerated registration, prequalification of Sputnik V vaccine

    The Prequalification of Medicines Programme is a United Nations programme managed by WHO. It is the only global medicines quality assurance programme. The WHO prequalification of medicines assesses the quality, safety and efficacy of medicines. RDIF said that a successful prequalification will enable Sputnik V to be included in the list of medicines used by international procurement agencies and countries to guide bulk purchasing of medicines.

    Drug regulator may meet this week to consider Sputnik trials

    Dr Reddy’s had in September entered into a partnership with Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V – the first registered vaccine against Covid-19 that has been approved by Russia, Argentina and Belarus among others — and the rights for distribution in India.

    DHL Global Forwarding transports Russia’s Sputnik V vaccine into India for clinical trials

    In a recent white paper, its parent Deutsche Post DHL said there would be a global requirement of 200,000 pallet shipments and 15 million deliveries in cooling boxes as well as 15,000 flights across various supply chain setups for the vaccine.

    First batch of Sputnik V vaccine to arrive in Kanpur medical college for Phase 2, 3 trials

    The decision to conduct the human clinical trials of the vaccine was taken after Dr Reddy's Laboratories got approval from the Drugs Controller General of India (DCGI) in this regard, an official said.

    Dr Reddy's partners with Department of Biotechnology for Sputnik V vaccine clinical trials in India

    Chairman of Dr Reddys Laboratories, Satish Reddy said, "We are pleased with the collaboration with BIRAC as an advisory partner for clinical trials of the Sputnik V vaccine in India. We look forward to working with them to accelerate our efforts in bringing the vaccine to India."

    Dr Reddy's Labs begins phase 2/3 trials for Russia's Sputnik V COVID-19 vaccine

    JSS Medical Research was roped in as clinical partner to conduct the multi-centre and randomised controlled study that includes safety and immunogenicity study, Dr Reddy's & RDIF said in a joint statement.

    Dr Reddy’s receives DCGI’s approval to conduct clinical trial for Sputnik V vaccine in India

    In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India.

    With approvals Sputnik V delivery in India possible by end of 2020: Kirill Dmitriev, CEO, RDIF

    The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund has tied up with India's Dr Reddy’s Laboratories to conduct the clinical trials and distribution of Sputnik V vaccine in India. ET’s Divya Rajagopal caught up with CEO RDIF, Kirill Dmitriev to understand when the vaccine will be available in India. WatchWith approvals Sputnik V delivery in India possible by end of 2020: Kirill Dmitriev, CEO, RDIF

    Russia's Sputnik V COVID-19 vaccine will cost less than $20 per person internationally

    The pricing announcement comes as Russia looks to scale up distribution and production. Kirill Dmitriev, head of Russia's RDIF sovereign wealth fund, said Moscow and its foreign partners had capacity to make more than a billion doses starting from next year, enough to vaccinate over 500 million people.

    India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks: Executive

    Indian trials of the Sputnik-V vaccine candidate, being developed by Russia's sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals across the country, Deepak Sapra, CEO for API and pharmaceutical services at Dr. Reddy's, told Reuters.

    Twenty-six scientists question early-stage trial results of Russia's Sputnik-V vaccine

    Twenty-six scientists, most of them working at universities in Italy, have signed an open letter questioning the reliability of the data presented in the early-stage trial results of the Russian COVID-19 vaccine, named "Sputnik-V".

    COVID-19 positivity rate is on decline; India-Russia in talks on Sputnik-V vaccine: Govt

    The Union Health Ministry on Tuesday said though COVID-19 testing has been increased exponentially, there has been a steady decline in the positivity rate and highlighted that the number of active cases of the infection reduced by 6,423 for the first time in a span of 24 hours. Asked whether the Russian government has placed any formal request for the manufacturing of its COVID-19 vaccine in India, Bhushan said as far as the vaccine Sputnik V developed by Russia is concerned, "both the countries (India and Russia) are in communication. Some initial information has been shared while some detailed information is awaited".COVID-19 positivity rate is on decline; India-Russia in talks on Sputnik-V vaccine: Govt

    It is ridiculous to build DRL earnings expectations based on Russia vaccine tieup: Sandip Sabharwal

    ‘ The Russian vaccine is not an approved vaccine and hardly any trials have taken place.’

    Sputnik-V COVID vaccine: Russia's RDIF collaborates with Dr Reddy's Laboratories for trials, distribution

    The Russian Direct Investment Fund has collaborated with Indian pharma giant Dr Reddy's Laboratories to conduct clinical trials of the Sputnik V vaccine against COVID-19 as well as its distribution, RDIF CEO Kirill Dmitriev said on Wednesday. The RDIF is in talks with Indian regulators to ensure that all the requirements for clinical trials are being met, he said.Sputnik-V COVID vaccine: Russia's RDIF collaborates with Dr Reddy's Laboratories for trials, distribution

    RDIF and Dr Reddy's tie up to manufacture coronavirus vaccine Sputnik V for India

    Adding that the platform of human adenoviral vectors, which is the core of the Russian vaccine, has been tested in more than 250 clinical studies over decades, and it has been found safe with no potential negative long-term consequences.”

    Russia names its coronavirus vaccine as 'Sputnik V' in reference to world's first satellite

    Russia has named its first approved coronavirus vaccine 'Sputnik V' for the foreign markets. It is a reference to the world's first satellite Sputnik and what Moscow sees as its success at becoming the first country to approve a vaccine, a top official said.Russia names its coronavirus vaccine as 'Sputnik V' in reference to world's first satellite

    Sputnik-V registration crosses 1 billion mark in 37 countries

    Efficacy of Sputnik-V is 91.6% as confirmed by the data published in the Lancet, one of the world's oldest and most respected medical journals; it is one of only three vaccines in the world with efficacy of over 90%; Sputnik V provides full protection against severe cases of COVID-19.

    More jabs on way: Three candidates to file final data, launch phase-3 trials

    Biological E, Dr Reddy’s Laboratories and Serum Institute of India are preparing to submit data for approval of their Covid-19 vaccines or to start phase-3 trials. Bharat Biotech will release its phase-3 efficacy data in the next two weeks as well.

    South Africa says J&J, Pfizer, Moderna vaccines considered for "immediate use"

    Health Minister Zweli Mkhize said the government had placed "huge orders on J&J and Pfizer which will be finalised in the next few days and announced when concluded", adding that discussions with Moderna were ongoing.

    Selling vaccine at capped prices not sustainable, say manufacturers

    The government last week opened vaccinations for those who are above the age of 60 as well as those in the 45-60 age group with comorbidities. It also opened vaccination in private hospitals, but capped the price.

    Dr Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid vaccine

    “The Indian clinical trial being conducted by Dr Reddy’s and RDIF is an adaptive design phase 2/3 trial. It is a bridging study to the larger global phase 3 study on 31,000 subjects. The phase 2 study in India showed a very good safety profile, said Dr. Reddy’s co-chairman G V Prasad.

    Vladimir Putin decides to receive coronavirus vaccine - Kremlin

    Russia launched a voluntary vaccination programme with the Russia-made Sputnik V vaccine earlier in December, starting with the most vulnerable groups in Moscow.

    COVID-19 vaccine clinical trials: 17 volunteers given doses of Russia's Sputnik V in Pune

    Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.

    Russia approves its third COVID-19 vaccine: Prime Minister Mikhail Mishustin

    Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results.

    AstraZeneca to test combining COVID-19 vaccine with Russian shot

    The developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.

    EU's anti-fraud body warns against COVID-19 vaccine scams

    In a statement Monday, OLAF said it was made aware of a number of reports of scammers offering to sell vaccines in a bid to defraud EU governments trying to speed up the pace of vaccination.

    Vladimir Putin orders mass coronavirus vaccinations in Russia from next week

    Russia has imposed no broad lockdown during the second wave of infections that began in September and officials have said that targeted restrictions are enough to curb the virus.

    Iran imposes mandatory quarantine for travellers from Europe

    Travellers from other regions, including neighbouring countries, will have to have tested negative before arrival in the country, Alireza Raisi, spokesman for the national coronavirus task force, said on state TV.

    Dr Reddy's to seek approval for Sputnik V jab by March

    In September last, Dr. Reddy's partnered with Russian Direct Investment Fund (RDIF) to conduct the clinical trials of the Sputnik V vaccine and for its distribution rights in India.

    Dr Reddy’s Q3 results: Net profit at Rs 19.8 crore, sharply lower than Street estimates

    The company’s consolidated revenues grew 12 per cent on year to Rs. 4,930 crore, which was largely in-line with analysts’ estimate of Rs. 4,975 crore.

    Russia repeats 91.4% efficacy rate in new COVID-19 vaccine data: Developers

    The new results are based on data from 22,714 participants in the trial, and were published after 78 confirmed coronavirus cases were reported among the group, researchers at the Gamaleya Institute said in a statement made on Monday with the Russian Direct Investment Fund, which is marketing the shot.

    Dubai's Emirates seeks key role in global vaccine delivery

    Emirates also is assembling a wide-ranging supply chain across the world, catering particularly to countries in Africa and the Middle East that lack the proper infrastructure to store and transport the shots.

    Can we avoid another coronavirus pandemic?

    Trials have been on in Europe and Latin America since December, and the results could be out as early as next month. The good news is that, unlike the Pfizer shot that needs to be stored at -70°C, the CureVac shot can be stored safely at +5°C (in an ordinary refrigerator) for three months.

    Pakistan says China's Sinopharm vaccine not effective for people over 60 years

    China has said that it is currently conducting field trials for 16 vaccines, while it has so far granted conditional approval to Sinopharm, even as it began supplying the shot to a number of countries, including Pakistan.

    How did India's Big Pharma fare in the December Quarter?

    Sun Pharma reported its highest-ever quarterly sales, and Cipla posted the highest-ever Ebitda margin in the company's recent history. Lupin's Ebitda margin improved for the fourth consecutive quarter.

    Indian partners to make Russian vaccine for supply to Argentina

    ​​The announcement came on Tuesday when the President of Argentina Alberto Fernandez said in an interview his country will be getting supply of the Covid vaccines from Russia.

    India seeks funds from Quad alliance to match China's vaccine push-source

    Beijing has committed to provide at least 463 million doses of its home-made COVID-19 vaccines through exports and donations across the world from Asia to Africa, Europe and Latin America, according to Reuters calculations.

    Russia agrees to produce coronavirus vaccine Sputnik V in India, set to work with Hetero

    Hetero and the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it globally, plan to start production of Sputnik V in India at the beginning of 2021, the statement said.

    1,000 volunteers prepare for second dose of Covaxin

    Dr JS Kushwaha, principal investigator at Prakhar hospital, said: "The second dose of Covaxin would also be administered to these 1,000 volunteers from January 3. First dose of this vaccine was given to volunteers from different walks of life."

    India stands firm on S-400 purchase: Defence needs are determined independently says envoy to Moscow

    When asked about India’s resolve to go ahead with the S-400 purchase, Varma said, “I will only say that all of our partners in military-technical sphere know about the policy and the defence needs of India.”

    Iran urges Biden to lift sanctions affecting medicines as it fights COVID-19

    Sanctions reimposed by former U.S. President Donald Trump formally exempt food, medicine and other humanitarian supplies, but many foreign banks have been deterred from doing business with Iran.

    Moscow to open COVID-19 vaccination centres on Saturday: Mayor

    President Vladimir Putin on Wednesday ordered a large-scale voluntary vaccination programme against COVID-19 to begin next week across Russia, saying teachers and doctors should be first in line to get the flagship Sputnik V vaccine.

    ‘There’s nothing like herd immunity at the moment … we must take our vaccines, continue with Covid protocols’

    "This is an emergency that we’re all talking about, where time is critical. Every day people are getting infections, many are dying of them. We have not gone through a pandemic earlier, and there’ll be viewpoints and positions, and we can debate and discuss those."

    Expert panel to submit report soon on priority individual for COVID vax

    Paul, who is also the chairman of the National Expert Group On Vaccine Administration for COVID-19 (NEGVAC) said this committee has gone deeply into it and looked at which comorbidities -- the presence of two or more diseases or medical conditions in a patient -- should be kept in mind.

    Covid-19: More than 100 million vaccinated

    None of the world's 29 poorest countries has formally started mass vaccination drives, while the richest nations have given more than two-thirds of jabs administered.

    Vaccine makers plan direct talks with states, private companies

    Prime Minister Narendra Modi had on Monday said the vaccine will be free for the first 30 million priority recipients – 10 million healthcare workers and 20 million frontline workers across the country. The government has not made it clear whether it will purchase doses for other identified high-risk groups .

    Russia to try out 'Sputnik-Light' COVID vaccine to make it go further

    According to authorities, over a million Russians have so far been inoculated with the original two-dose version of Sputnik V, named after the Soviet-era satellite that triggered the space race in a nod to the project's geopolitical importance for Moscow.

    Russia begins mass trials of second coronavirus vaccine

    EpiVacCorona, which is being developed by Siberia’s Vector Institute, was authorized this month to carry out trials on 150 volunteers over 60 and 3,000 volunteers over 18, the watchdog has said.

    Dr Reddys hopes to finish Phase 3 trials of COVID-19 vaccine by March-May

    Dr. Reddys and Russian Direct Investment Fund (RDIF), Russias sovereign wealth fund, entered into a partnership last month to conduct clinical trials of Sputnik V and its distribution in India.

    All Indo-Russian defence contracts implemented as per schedule: Foreign Secretary

    India does not see the Indo-Pacific Region as a club of limited members nor as a new theatre for geostrategic contestation. It includes all nations in this geography as also others beyond who have a stake in it aimed at Security and Growth for All in the Region (SAGAR), he emphasised.

    Gurgaon company’s technology to cart vaccines at desired temperature

    The application, which is based on what is called ‘phase-change’ technology, uses safe chemicals to provide solutions for the pharmaceutical industry, logistics and can even be used for cooling and heating buildings.

    Hyderabad set to emerge as global hub for Covid-19 vaccine in 2021

    The vaccine development process by Bharat Biotech, Biological E Ltd and Aurobindo Pharma are currently in various stages, while Dr Reddy's and Hetero have tie ups for manufacturing the vaccine.

    See which country is leading the global race to vaccinate

    Two of the countries with among the world’s highest vaccination rates, the UAE and Bahrain, are also using a vaccine developed by the Chinese company Sinopharm, which has not been approved for use in the US or the EU.

    Days after Russian COVID-19 vaccine trial approval, data breach forces Dr Reddy's plants shut

    In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India.

    Tata in talks to launch Moderna vaccine in India

    Tata Medical & Diagnostics, a newly formed subsidiary of Tata Sons, is said to have started initial discussions with US company Moderna for a partnership to launch its Covid-19 vaccine in India.

    Second human trials of Russian COVID-19 vaccine abroad, in UAE, have launched - Kremlin

    The trials in the UAE are the second trials of the Sputnik V vaccine abroad, following the launch of trials in Belarus. Trials are also expected to begin in Venezuela in the near future.

    Mankind pharma collaborates with Russian RDIF for distribution of Sputnik V in India

    Earlier in September, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.

    Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland China

    Fosun said it will be entitled to 60% of annual gross profit from sales of doses that it will make from imported bulk ingredients, and 65% of profit from sales of doses imported ready for use.

    WB to likely lose chance to conduct Phase II trial of Sputnik V for want of govt approval

    The trials were proposed to start at the state-run College of Medicine and Sagore Dutta Hospital (CMSDH) in North 24 Parganas district adjoining Kolkata later this week along with six other centres in different parts of the country.

    Clinical trial of Sputnik V Coronavirus vaccine to begin this month in countries including India: RDIF

    Russia was in close dialogue with the Indian government and the leading drug manufactures of India regarding the localization of production of Sputnik V vaccine in India.

    Capacity needed to manufacture Covid vaccines is unprecedented: DRL MD

    Prasad in an exclusive interview to ET said that three challenges with the Covid vaccine distribution are the sheer capacity expansion that companies have to prepare for manufacturing vaccines at this scale; the logistical issues with storage, and people training.

    Wheels only, please: Iran marks 1979 revolution anniversary

    "There is no other way for the world and for the region," Rouhani said during a televised speech. "The only path is definitely the path of diplomacy. The only path is the world's agreement with Iran. God willing, we will be successful in this path."

    Where are we in the COVID-19 vaccine race?

    AstraZeneca said on Nov. 23 it will immediately prepare the data to submit to regulatory authorities around the world that offer conditional or early approval.

    What do vaccine efficacy numbers actually mean?

    Efficacy is a crucial concept in vaccine trials, but it’s also a tricky one. If a vaccine has an efficacy of, say, 95%, that doesn’t mean that 5% of people who receive that vaccine will get COVID-19. And just because one vaccine ends up with a higher efficacy estimate than another in trials doesn’t necessarily mean it’s superior.

    Where are we in the COVID-19 vaccine race?

    U.S. drugmaker Pfizer Inc and German partner BioNTech SE released final late-stage trial data on Nov. 18 that showed their shot was 95% effective at stopping COVID-19, the highest efficacy rate so far.

    Moscow starts mass COVID-19 vaccination with its Sputnik V shot

    The task force said the Russian-made vaccine would first be made available to doctors and other medical workers, teachers and social workers because they ran the highest risk of exposure to the disease.

    Vaccines that can help India in its fight against Covid-19

    Experts have said that vaccines like Pfizer that requires super-cold storage may not be ideal for India and will pose a logistical hurdle.

    EU defends vaccine trials as UK gives first OK

    British ministers claimed Brexit has allowed them to adopt the Pfizer-BioNTech vaccine ahead of their neighbours, who are still awaiting a green light from the European Medicines Agency (EMA).

    Russia approves second coronavirus vaccine after early trials

    The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia and tested among 100 volunteers in early-stage, placebo-controlled human trials, which lasted more than two months and were completed two weeks ago.

    Putin says all Russian COVID-19 vaccines are effective, according to news agency

    Putin said Moscow was ready to cooperate with all other countries on coronavirus vaccines, but urged against politicising the process, the day after vaccine developers Pfizer Inc and BioNTech said their experimental COVID-19 vaccine was more than 90% effective.

    Where are we with coronavirus vaccines? Here are the promising nine

    There were several developments regarding vaccines and drugs this week, including the tie-up between the makers of Russia’s Sputnik V vaccine and Dr Reddy’s.

    Dr Reddy's Laboratories to submit a revised protocol for conducting clinical trials of Russian COVID-19 vaccine

    In a meeting held on Monday, Subject Expert Committee (SEC) on COVID-19 at the CDSCO, deliberated on the application and asked the firm to resubmit a revised protocol as it was not satisfied with the data of Phase II trials submitted by the company, sources told ET.

    Dubai halts live entertainment at hotels and restaurants amid surge in coronavirus cases

    Both decisions come after months of Dubai promoting itself as the ideal pandemic-friendly vacation spot while coronavirus infections skyrocketed. Now, the sheikhdom is showing signs of strain.

    Indian vaccine makers - Serum and Gennova - set to host over 20 foreign diplomats this week

    The move comes as the Indian government thinks that it has sufficient doses of vaccine for its population and can also supply to other nations that might be left out in the Covid-19 vaccine race as countries in Europe and US secure their own doses, said an official.

    WHO plans slew of COVID-19 vaccine approvals for global rollout: Document

    COVAX, a global scheme co-led by the WHO, wants to deliver at least 2 billion COVID-19 doses across the world this year, with at least 1.3 billion going to poorer countries.

    Stocks in the news: HDFC Bank, Metropolis Healthcare, IndiaMart, Mindtree, DHFL & GE T&D India

    IRB Infra, Indiabulls Real Estate, Snowman Logistics are some of the companies which will disclose their December quarter earnings during the day.

    DCGI seeking more data for authorisation won't impact vaccine roll-out: Govt

    "This situation was factored-in from before as it is emergency use authorisation. There should be more than reasonable satisfaction about the safety, immunogenicity and effectiveness of the vaccine," NITI Aayog member (health) Dr V K Paul said.

    India may have 500 million Covid-19 vaccine doses by March

    ​​Companies such as Zydus Cadila, Bharat Biotech, Dr Reddys-Gamaleya Institute, Serum Institute-AstraZeneca and Gennova are expected to submit their safety and efficacy data for approval with the drug regulator.

    India, Russia ties strong enough to navigate complexities of present world: Foreign Secretary Shringla

    Shringla said India does not see the Indo-Pacific Region as a club of limited members nor as a new theatre for geostrategic contestation. "It includes all nations in this geography as also others beyond who have a stake in it aimed at Security and Growth for All in the Region (SAGAR)," he said.

    Kazakhstan, European nations keen to buy vaccines from India

    Kazakhstan, Central Asia’s biggest state and India’s largest trade partner in the region, is open to the idea of both purchasing vaccines from India as well as entering into joint collaboration, ambassador Yerlan Alimbayev, who was part of the team, told ET.

    Not without India: World's biggest medicine maker gears up for coronavirus vaccine race

    India manufactures more than 60% of all vaccines sold across the globe, and while its $40 billion pharmaceutical sector is not yet involved in the production of the expensive Pfizer Inc and Moderna shots, the nation will play a pivotal role in immunizing much of the world.

    Goldman’s weaker dollar call adds to emerging-market fervor

    MSCI Inc.’s index tracking developing-nation currencies climbed to a record on Friday as the dollar posted its biggest weekly drop in 2021, even as U.S yields rose.

    The Economic Times
    BACK TO TOP